Skip to main content
Clinical Trials/IRCT20140102016035N3
IRCT20140102016035N3
Recruiting
Phase 3

Clinical Trial Of Investigation of Efficacy of Metformin on the Body Mass Index of Patients under Treatment with Selective Serotonin Re uptake Inhibitors Drugs Referred to Psychiatry Clinics of Rasht

Rasht University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Condition 1: Obesity. Condition 2: Depression. Condition 3: Anxiety Disorders.
Sponsor
Rasht University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Obtain informed consent from patients
  • No history of side effects with metformin and SSRI drugs
  • The absence of kidney and liver disorders
  • The absence of a physical illness such as diabetes and Autoimmune disease
  • No taking Corticosteroids
  • Not taking any type of drug and stimulant
  • The absence of psychotic features

Exclusion Criteria

  • Having metabolic disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials